Skip to main content
Premium Trial:

Request an Annual Quote

NIH to Award $64M for Transformative Research

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Institutes of Health has issued a number of new grants that will total $12.8 million in 2010 and up to $64 million over five years to a number of new and innovative research projects that may be high in risk but offer high rewards.

The NIH Director's Transformative Research Projects awards (TR01) program is aimed at allowing "investigators to sidestep conventional stumbling blocks they often face when applying for high-risk research, such as the need for preliminary data or a restriction on the amount of funds that can be requested," NIH said in an announcement of the funding on Thursday.

This batch of Transformative Research grants will fund a wide range or efforts including innovative and original projects focused on enhancing the power of DNA sequencing and other genome and gene-based applications, such as personalized medicine and rapid diagnostics.

"Complex research projects, even exceptionally high-impact ones, are tough to get funded without the necessary resources to assemble teams and collect preliminary data," NIH Director Francis Collins said in a statement. "The TR01 awards provide a way for these high impact projects to be pursued."

Among the fiscal-year 2010 grant winners:

• Researchers at Massachusetts General Hospital and Massachusetts Institute of Technology will receive $670,000 in 2010 to use genomic, synthetic biology, and protein engineering approaches to develop light-inducible transcription regulators targeted at specific genes in mammalian genomes. The aim is to develop and then use a platform that uses light-inducible transcriptional effectors to regulate multiple genes in both individual cells in vitro and in the intact organism.

• Scientists at New York University School of Medicine plan to use the $1.3 million it will receive in 2010 to study how the human body's bacterial populations have been altered by antibiotic use and other factors, and how that may have affected child development and predisposed children to obesity.

• University of Texas, Austin, researchers will receive $300,000 in 2010 to study DNA circuits for use in development of point-of-care diagnostics. They aim to determine if DNA circuits can be used to generate low-cost diagnostics for resource-poor settings and for point-of-care applications.

• MIT researchers also will receive $410,000 in 2010 to use DNA sequencing to generate knowledge of protein functions and protein interactions and to design custom molecules for research and therapeutic applications. Knowledge of how these interactions occur in healthy and diseased cells could lead to new treatments.

• Cold Spring Harbor Laboratory scientists will use $440,000 in 2010 funding to develop a method for using high-throughput DNA sequencing to study the connectivity of neural circuits at the single-neuron level. The goal is to identify the connections that when lost are involved in diseases such as autism, schizophrenia, Alzheimer's disease, and mental retardation.

The full list of 2010 award winners can be found here.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.